Background and Purpose This prospective longitudinal study identifies early diffusion tensor imaging biomarkers of mild traumatic brain injury that significantly relate to outcomes at 1 year following injury. Materials and Methods DTI was performed on 39 mild traumatic brain injury subjects within 16 days of injury and 40 controls; 26 mild traumatic brain injury subjects returned for follow-up at 1 year. We identified subject-specific regions of abnormally high and low fractional anisotropy, and calculated mean fractional anisotropy, axial diffusivity, radial diffusivity, and mean diffusivity across all white matter voxels brain-wide, and across each of several white matter regions. Assessment of cognitive performance and symptom burden was performed at 1 year. Results Significant associations of brain-wide DTI measures and outcomes included: mean radial diffusivity and mean diffusivity with memory; mean fractional anisotropy, radial diffusivity and mean diffusivity with health-related quality of life. Significant differences in outcomes were found between subjects with and without abnormally high fractional anisotropy for the following white matter regions and outcome measures: left frontal lobe and left temporal lobe with attention at 1 year, left and right cerebelli with somatic post-concussion symptoms at 1 year, and right thalamus with emotional post-concussion symptoms at 1 year. Conclusion Individualized assessment of DTI abnormalities significantly relates to long-term outcomes in mild traumatic brain injury. Abnormally high fractional anisotropy is significantly associated with better outcomes, and might represent an imaging correlate of post-injury compensatory processes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.